000			01692 a2200421 4500
005			20250515013851.0
264		0	_c20060404
008			200604s 0 0 eng d
022			_a0028-3835
024	7		_a10.1159/000091206 _2doi
040			_aNLM _beng _cNLM
100	1		_aD'Astous, Myreille
245	0	0	_aDifferential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice. _h[electronic resource]
260			_bNeuroendocrinology _c2005
300			_a111-20 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAutoradiography
650	0	4	_aDopamine Plasma Membrane Transport Proteins _xmetabolism
650	0	4	_aDopamine Uptake Inhibitors _xantagonists & inhibitors
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEnkephalins _xmetabolism
650	0	4	_aEstradiol _xtherapeutic use
650	0	4	_aEstrogen Antagonists _xtherapeutic use
650	0	4	_aIn Situ Hybridization
650	0	4	_aMethamphetamine _xantagonists & inhibitors
650	0	4	_aMice
650	0	4	_aNeurotoxicity Syndromes _xprevention & control
650	0	4	_aProtein Precursors _xmetabolism
650	0	4	_aSubstantia Nigra _xdrug effects
650	0	4	_aTamoxifen _xtherapeutic use
650	0	4	_aVesicular Monoamine Transport Proteins _xmetabolism
700	1		_aMickley, Katherine R
700	1		_aDluzen, Dean E
700	1		_aDi Paolo, Thérèse
773	0		_tNeuroendocrinology _gvol. 82 _gno. 2 _gp. 111-20
856	4	0	_uhttps://doi.org/10.1159/000091206 _zAvailable from publisher's website
999			_c16060539 _d16060539